
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Keypoint Newsletter: AI in Biomedicine Virtual Meeting
AI and Machine learning are transforming biomedical research at an astounding pace, enabling...
Keypoint Newsletter: Announcing Our New 2-Day Conference Format
We are pleased to announce the launch of a new 2-day conferece format for conferences on emerging...
Keypoint Newsletter: Whats the Buzz?
As we wrap up our fall season, the community has taken to Twitter/X with rave reviews and...
Keypoint Newsletter: Health Equity in Vaccinology
In addition to covering emerging developments in vaccine science, design and technology, the ...
Keypoint Newsletter: The Birth of a Conference
Keystone Symposia conferences hold a special place in science for their ability to drive...
Nobel Laureate Dr. Jim Allison talks about his Upcoming Cancer Immunotherapy Meeting and the Evolution of the Field
2018 Nobel Laureate Dr. Jim Allison, and organizer of the 2024 Keystone Symposia on Cancer...
Health Equity in Vaccinology: Keynote Address by Dr. Barney Graham and more!
In addition to covering emerging developments in vaccine science, design and technology, the ...
Keystone Symposia Climate Initiatives
Over the course of the last 50 years, Keystone Symposia has convened conferences that connect...
Keypoint Newsletter: September 2023
Welcome to the Keypoint Newsletter, bringing you all the latest news & views from Keystone...